All articles tagged with #male birth control
A non-hormonal male birth control pill called YCT-529 has passed initial safety tests in humans, showing promise as a reversible and side-effect-free contraceptive option, with larger studies underway.
A hormone-free male birth control pill called YCT-529 has successfully passed its initial safety test in humans, showing no significant side effects in a small trial, and is now moving into larger studies to evaluate its safety and effectiveness in preventing sperm production and offering a new contraceptive option for men.
A hormone-free male birth control pill called YCT-529 has successfully passed its initial safety test in humans, showing no significant side effects and paving the way for larger trials to assess its safety and effectiveness in preventing sperm production.
A combination hormonal topical gel for male birth control has shown promise in early-stage clinical trials by effectively suppressing sperm production in a shorter time frame. The Phase 2b trial, involving 222 men, demonstrated that 86% of participants achieved the desired low sperm count by Week 15. The gel, developed by the Population Council and the National Institutes of Health, offers a potential new contraceptive method for men, marking a significant milestone in reproductive health.
A new hormonal gel for male birth control has shown promising results in a phase 2 trial, with 86% of participants achieving effective sperm suppression within 12 weeks. The gel, which combines testosterone and the synthetic hormone Nestorone, could offer a reversible and convenient contraceptive option for men if approved by the FDA. Despite the positive findings, further trials and significant funding are needed to bring the product to market.
A new hormonal gel for male birth control has shown promising results in a phase 2 trial, with 86% of participants achieving effective sperm suppression within 12 weeks. The gel, which combines testosterone and the synthetic hormone Nestorone, is easy to use and has minimal side effects. Researchers are hopeful for FDA approval, but further trials and significant funding are needed to bring the product to market. Interest in male contraception is growing, especially following the Supreme Court's decision to overturn Roe v. Wade.
Preliminary research on the NES/T gel, a male birth control option, shows it can suppress sperm counts faster than expected, with many men achieving suppression within eight weeks. The gel, which combines nestorone and testosterone, aims to maintain stable hormone levels and minimize side effects. Early results from a Phase IIB trial are promising, and further studies are planned to bring the product to market.
Researchers at Baylor College of Medicine have made significant progress towards developing a male birth control pill by identifying a compound that inhibits a protein crucial for male fertility. The compound, which has shown temporary contraceptive effects in mice, will need further testing on non-human primates before human trials can begin. This development represents a potential breakthrough in male contraception, which has faced numerous challenges over the years.
The Salk Institute has developed a non-hormonal and reversible male contraceptive method using HDAC inhibitors to block sperm production without affecting libido, offering a significant advancement in male birth control. Administering an HDAC inhibitor orally stopped sperm production and fertility in mice without impacting their libido, and the effects were fully reversible. This novel approach targets the regulation of gene expression in sperm production, providing a promising therapeutic approach for human clinical trials.